The first experimental confirmation that oncogenic BRAFV600E (BRAF), mutated in 40–50% of human melanomas [25–27], can promote nevi (moles) and melanoma formation was demonstrated in zebrafish [7]. The gene discussed is BRAF; the disease is melanoma.